1.	Phase III Randomized Study of Paclitaxel Versus Polyglutamate Paclitaxel as Consolidation/Maintenance Therapy Versus No Further Anticancer Therapy Until Disease Progression in Patients With Stage III or IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: NCI Protocol IDs: GOG-0212, NCT00108745
2.	Phase III Randomized Study of Paclitaxel Poliglumex and Carboplatin Versus Paclitaxel and Carboplatin in Women With Chemotherapy-Naïve Stage IIIB or IV or Recurrent Non-Small Cell Lung Cancer and Estradiol > 30 pg/mL Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CTI-PGT-07-00400, PGT-06-0040(0), EUDRACT-2007-004167-22, NCT00551733
3.	A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: X90003, NCT00660218
4.	PPX and Concurrent Radiation for Newly Diagnosed Glioblastoma Without MGMT Methylation Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: BrUOG 244, NCT01402063